Ticker ALNA – Allena Pharma – sales, description, marketcap – Tickerday.com

ALNA

Allena Pharma

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 46.12M; Volume: 426.32K; AvgVol 3m: 1.81M; Beta: ;

Cost estimate:

P/E: ; EPS: -1.62; EPS growth quarter/prev quarter: 51.90%;

EPS growth this year: -24.20%; EPS growth past 5 years: ;

EPS ttm: -1.62;

P/S: ; P/B: 2.43; P/Cashflow: 2.54; P/FCF: ;

Sales: ; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -121.00%; ROE – return on equity: -219.60%; LT Debt/Equity: 0.22; Total Debt/Equity: 0.43;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 10.16%; Insider Transactions:0.00%;

Institutional Ownership: 45.60%; Institutional Transactions: 12.55%;

Data update: 07.10.2020.

Leave a comment

Your email address will not be published. Required fields are marked *